Quarterly report pursuant to Section 13 or 15(d)

Balance Sheets (Unaudited)

v2.4.0.6
Balance Sheets (Unaudited) (USD $)
Mar. 31, 2012
Sep. 30, 2011
CURRENT ASSETS    
Cash $ 775,341 $ 469,786
Prepaid expenses 441,018 37,611
Grant receivable    179,358
Other current assets    5,000
Total Current Assets 1,216,359 691,755
EQUIPMENT, net 47,839 19,164
OTHER ASSETS    
Patent costs, net 662,655 701,927
TOTAL ASSETS 1,926,853 1,412,846
CURRENT LIABILITIES    
Accounts payable and accrued expenses 313,634 301,055
Notes payable 48,300   
Derivative liabilities 2,258,888 5,893,544
Total Current Liabilities 2,620,822 6,194,599
TOTAL LIABILITIES 2,620,822 6,194,599
STOCKHOLDERS' EQUITY (DEFICIT)    
Preferred stock, Series B; 6,000,000 shares authorized, at $0.0001 par value, 5,583,336 and 5,583,336 shares issued and outstanding, respectively 558 558
Common stock; 180,000,000 shares authorized, at $0.0001 par value, 41,702,589 and 39,702,580 shares issued and outstanding, respectively 4,170 3,970
Additional paid-in capital 27,438,395 22,289,231
Accumulated deficit (21,628,748) (21,628,748)
Deficit accumulated during the development stage (6,508,344) (5,446,764)
Total Stockholders' Equity (Deficit) (693,969) (4,781,753)
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY (DEFICIT) $ 1,926,853 $ 1,412,846